Arkolith/Insider Trading/AKBA/Form 4

Butler John P.

CEO and President, DirectorAkebia Therapeutics, Inc. (AKBA) · full profile →Form 4 · filed Feb 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$303K
Net Open-Market Flow
-$303K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 3, 2025Sell(S)46K$2.10$97K2.7M
Feb 3, 2025Sell(S)98K$2.10$206K2.6M
Jan 31, 2025Grant(A)701K—$02.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2025Grant(A)1.1M—$01.1M
Jan 31, 2025Grant(A)351K—$0351K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-000917) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML